Evo Fund lowers stake in Oncolys BioPharma to 6.78%
Stake history
Summary
Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2024-10-21 10:19 JST concerning Oncolys BioPharma Inc. Reported holding ratio: 6.78%, previous report: 7.93%.